ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industry, has announced that its engineering business, which is dedicated to aftermarkets service, is working with its manufacturing customers to increase the life cycle of their machines.
The company wants to ensure that its customers do not add to their productivity concerns and is helping them to remove any avoidable interruptions to their production while enhancing performance.
ACG engineers analyze machines worldwide and help owners and operators find better working methods.
From electronic upgrades to updated original equipment manufacturer (OEM) parts, ACG’s customers can reduce changeover and setup times and improve yield and operator safety standards.
By upgrading, rather than replacing, machines can sustain less wear and tear, run more smoothly, and last longer.
Additionally, the ACG team is helping its customers with aging machines achieve 21 CFR Part 11 compliance, the US Food and Drug Administration’s (FDA) regulation for electronic documentation and electronic signatures.
Depending on the type and age of an individual machine, the different methods for improving machine performance include production planning, condition monitoring, predictive maintenance, energy optimization, operator augmentation, and remote servicing. All are designed to help reduce costs and boost revenues and profit.
Ashish Karulkar, head of aftermarkets at ACG, said, “The message at the heart of our operation is ‘make it better’. A healthier world means providing affordable quality medicines and supplements safely to all areas of the planet with minimal environmental impact. Good machines are needed to make good medicines.”
Karulkar said 21 CFR Part 11 compliance is the need of the hour for all FDA-regulated customers. “ACG supports our customers to achieve this compliance effectively and provides them with critical real-time information. Even saving on digital storage is all part of how we continue to operate in these economically challenging times. In the coming times, the ACG-driven digital initiatives such as IoT and Smart Serve will help achieve our objective of enhancing performance and improving machine productivity.”
“At a time of unprecedented increases in manufacturing costs that extend to energy, raw materials, labor, and services, having a plant that not only lasts but supports production has never been more important,” Karulkar said.
ACG has been delivering solutions to the global pharmaceutical and nutraceutical industry for over 60 years, across six continents and in 100 countries. Its products range from capsules to films and foils to engineering equipment and inspection systems – all that meet international regulatory requirements.
